Search details
1.
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy.
Nature
; 629(8013): 919-926, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38589574
2.
Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD.
Blood
; 124(12): 1976-86, 2014 Sep 18.
Article
in English
| MEDLINE | ID: mdl-25079358
3.
Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis.
J Immunol
; 190(3): 1351-9, 2013 Feb 01.
Article
in English
| MEDLINE | ID: mdl-23275602
4.
Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8 T Cells.
Biol Blood Marrow Transplant
; 20(1): 26-36, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24141010
5.
Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma.
Res Sq
; 2024 Jan 18.
Article
in English
| MEDLINE | ID: mdl-38313265
6.
ALK upregulates POSTN and WNT signaling to drive neuroblastoma.
Cell Rep
; 43(3): 113927, 2024 Mar 26.
Article
in English
| MEDLINE | ID: mdl-38451815
7.
Simultaneous Imaging of Ga-DOTA-TATE and Lu-DOTA-TATE in Murine Models of Neuroblastoma.
IEEE Trans Radiat Plasma Med Sci
; 7(1): 75-82, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-37635919
8.
N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma.
Cancer Res
; 83(1): 130-140, 2023 01 04.
Article
in English
| MEDLINE | ID: mdl-36264168
9.
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.
Nat Med
; 28(2): 333-344, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35027753
10.
Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination.
Biol Blood Marrow Transplant
; 17(6): 790-9, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21216299
11.
Synergistic Anti-Tumor Effect of Combining Selective CDK7 and BRD4 Inhibition in Neuroblastoma.
Front Oncol
; 11: 773186, 2021.
Article
in English
| MEDLINE | ID: mdl-35198433
12.
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53.
Neoplasia
; 23(6): 624-633, 2021 06.
Article
in English
| MEDLINE | ID: mdl-34107377
13.
Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma.
J Immunother Cancer
; 9(6)2021 06.
Article
in English
| MEDLINE | ID: mdl-34083417
14.
Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling.
Cancer Cell
; 34(6): 922-938.e7, 2018 12 10.
Article
in English
| MEDLINE | ID: mdl-30537514
15.
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2.
J Clin Invest
; 128(1): 446-462, 2018 01 02.
Article
in English
| MEDLINE | ID: mdl-29202477
16.
Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors.
Oncotarget
; 8(14): 23851-23861, 2017 Apr 04.
Article
in English
| MEDLINE | ID: mdl-27793021
Results
1 -
16
de 16
1
Next >
>>